Protein formulation
DCFirst Claim
1. A formulation comprising a lyophilized mixture of a non-reducing sugar, a humanized antibody, and histidine, wherein the molar ratio of non-reducing sugar to humanized antibody is within the range from 100 to 600 mole non-reducing sugar:
- 1 mole humanized antibody.
0 Assignments
Litigations
0 Petitions
Accused Products
Abstract
A stable lyophilized protein formulation is described which can be reconstituted with a suitable diluent to generate a high protein concentration reconstituted formulation which is suitable for subcutaneous administration. For example, anti-IgE and anti-HER2 antibody formulations have been prepared by lyophilizing these antibodies in the presence of a lyoprotectant. The lyophilized mixture thus formed is reconstituted to a high protein concentration without apparent loss of stability of the protein.
370 Citations
15 Claims
-
1. A formulation comprising a lyophilized mixture of a non-reducing sugar, a humanized antibody, and histidine, wherein the molar ratio of non-reducing sugar to humanized antibody is within the range from 100 to 600 mole non-reducing sugar:
- 1 mole humanized antibody.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
13. A sterile formulation comprising a lyophilized mixture of a non-reducing sugar and a humanized antibody, wherein the molar ratio of non-reducing sugar to humanized antibody is within the range from 200 to 600 mole non-reducing sugar:
- 1 mole humanized antibody.
- View Dependent Claims (14, 15)
Specification